CVRX
Companies
NASDAQ
CVRx, Inc.
Health Care
$5.85
-$6.82 (-53.83%)
Price Chart
Overview
About CVRX
cvrx is a private company located in minneapolis, minnesota. the company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. the barostim neo™ uses cvrx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. the barostim neo can be adjusted to meet each patient’s individual therapy needs.
Market Cap
$208.0M
Volume
1.0M
Avg. Volume
1.3M
P/E Ratio
-5.3925233
Dividend Yield
0.00%
Employees
192.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.03
Moderate Correlation
Volatility
High (0.88)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CVRX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$208.0M
Volume1.0M
P/E Ratio-5.39
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 5, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025